Dr. Kurrasch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
GlaxoSmithKline
1250 S. Collegeville Road Mailstop UP-4300
Collegeville, PA 19426Phone+1 484-612-2585- Is this information wrong?
Education & Training
- Johns Hopkins Public HealthMPH, Public Health, 1997 - 2001
- University of California (San Francisco)Fellowship, Rheumatology, 1982 - 1985
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1979 - 1982
- State University of New York Downstate Medical Center College of MedicineClass of 1979
Certifications & Licensure
- CA State Medical License 1982 - 2025
- MD State Medical License 1989 - 2024
- PA State Medical License 1998 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- 2 citationsEfficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses.Jie Zheng, Jieruo Gu, Yin Su, Yang Li, Xingfu Li, Cui Xiong, Hua Cao, Holly Quasny, Myron Chu, Paula Curtis, Kathleen DeRose, Regina Kurrasch, Paige Meizlik, David A R...> ;Modern Rheumatology. 2023 Jul 4
- 4 citationsPhase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years.Fengchun Zhang, Jie Zheng, Yang Li, Guochun Wang, Mingjun Wang, Yin Su, Jieruo Gu, Xingfu Li, Myron Chu, Paula Curtis, Kathleen DeRose, Regina Kurrasch, Jenny Lowe, Pa...> ;RMD Open. 2022 Apr 1
- 3 citationsThe effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study.Sang-Cheol Bae, Damon L Bass, Myron Chu, Paula Curtis, Richard Dimelow, Laurence Harvey, Beulah Ji, Regina Kurrasch, Saima Muzaffar, Raj Punwaney, David A Roth, Yeong-...> ;Arthritis Research & Therapy. 2022 Feb 16
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: